Linor Haimson

Head Of Clinical Operations And Product Leader at Clexio Biosciences

Linor Haimson has extensive experience in the pharmaceutical industry, with a focus on clinical operations and management. Linor is currently working at Clexio Biosciences as the Head of Clinical Operations and Product Leader, a position they have held since September 2023. Prior to this role, they served as the Head of Clinical Operations at Clexio Biosciences from September 2020 to September 2023. Before joining Clexio Biosciences, Linor worked at Teva Pharmaceuticals, where they held various positions including Associate Director and Head of Global Clinical Operations for Headache Studies from January 2016 to July 2018. Linor also served as a Senior Global Clinical Project Manager, CNS/Pain from March 2014 to January 2016, Head of IL Data Management from February 2012 to February 2014, and Head of Clinical Quality Control from September 2008 to January 2012. Linor's career at Teva Pharmaceuticals began in September 2006 as a CQC associate, a role they held until August 2008.

Linor Haimson completed their Master of Business Administration (MBA) degree in Biotech at The College of Management Academic Studies from 2019 to 2020. Linor also holds a Master of Science (MsC) degree in Genetics from Tel Aviv University, earned between 1999 and 2001. Prior to that, their education history includes attending The Hebrew Reali School, although specific details such as degree and field of study are not provided.

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Clexio Biosciences

Clexio Biosciences is a CNS-first clinical-stage pharmaceutical company. Our therapies are designed to address patients’ unmet needs through scientifically based integration of drugs with innovative technologies. Clexio’s growing pipeline is focused on the development of safe and effective treatments with rapid onset of action for a wide range of neurological and psychiatric conditions, including Major Depressive Disorder, Parkinson’s Disease, Pain and other conditions involving impairment of the neurological system. Patients, and what they are living with, are at the center of everything we do. Our passion is to find ways to help patients regain a sense of balance, health and a life worth living. Clexio’s team is comprised of a multi-disciplinary team with vast experience in drug development. We see our team and our partners as the key ingredients to our success. Join our vision to make lives of millions of patients worth living again.


Employees

11-50

Links